We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$812B
AUM Growth
-$55.8B
Cap. Flow
-$18.8B
Cap. Flow %
-2.31%
Top 10 Hldgs %
32.22%
Holding
3,109
New
91
Increased
2,002
Reduced
738
Closed
70

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.81B
2
XYZ
Block Inc
XYZ
+$1.46B
3
ACN icon
Accenture
ACN
+$1.23B
4
GILD icon
Gilead Sciences
GILD
+$1.15B
5
VLO icon
Valero Energy
VLO
+$1.05B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.61B
2
META icon
Meta Platforms (Facebook)
META
+$2.06B
3
TSLA icon
Tesla
TSLA
+$1.81B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.72B
5
AMZN icon
Amazon
AMZN
+$1.59B

Sector Composition

Rank Sector Weight
1 Technology 30.44%
2 Healthcare 13.92%
3 Financials 12.3%
4 Consumer Discretionary 10.98%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNGO icon
3026
Bionano Genomics
BNGO
$13.3M
-1,173
Closed -$20K
BNTX icon
3027
BioNTech
BNTX
$23.2B
-313,789
Closed -$35.8M
BYRN icon
3028
Byrna Technologies
BYRN
$99.2M
-7,036
Closed -$203K
CLF icon
3029
CALL
Cleveland-Cliffs
CLF
$6.99B
-9,007,600
Closed -$84.7M
CLMB icon
3030
Climb Global Solutions
CLMB
$529M
-6,580
Closed -$209K
CRBP icon
3031
Corbus Pharmaceuticals
CRBP
$191M
-164,735
Closed -$1.95M
KYNB
3032
Kyntra Bio
KYNB
$28.7M
-4,640
Closed -$61K
B
3033
Barrick Mining
B
$66.6B
-6,777,848
Closed -$105M
GPRK icon
3034
GeoPark
GPRK
$594M
-31,864
Closed -$296K
HBM icon
3035
Hudbay
HBM
$11.9B
-2,179,767
Closed -$17.7M
IMTX icon
3036
Immatics
IMTX
$1.31B
-2,461,592
Closed -$17.5M
IQ icon
3037
iQIYI
IQ
$1.25B
-14,900
Closed -$30K
IWM icon
3038
CALL
iShares Russell 2000 ETF
IWM
$82.7B
-53,300
Closed -$11.8M
KGC icon
3039
Kinross Gold
KGC
$31.8B
-4,725,256
Closed -$43.8M
KPTI icon
3040
Karyopharm Therapeutics
KPTI
$44.2M
-4,287
Closed -$44K
LFVN icon
3041
LifeVantage
LFVN
$82M
-20,700
Closed -$363K
MGPI icon
3042
MGP Ingredients
MGPI
$389M
-5,662
Closed -$223K
MOS icon
3043
CALL
The Mosaic Company
MOS
$7.13B
-1,745,591
Closed -$42.9M
MSBI icon
3044
Midland States Bancorp
MSBI
$705M
-8,228
Closed -$201K
NGNE icon
3045
Neurogene
NGNE
$728M
-123,291
Closed -$2.82M
NTR icon
3046
CALL
Nutrien
NTR
$32B
-2,218,700
Closed -$99.3M
OM icon
3047
Outset Medical
OM
$85.7M
-2,620
Closed -$44K
QMCO icon
3048
Quantum Corp
QMCO
$914M
-5,030
Closed -$272K
QSR icon
3049
Restaurant Brands International
QSR
$26.9B
-150
Closed -$10K
REPX icon
3050
Riley Exploration Permian
REPX
$782M
-28,058
Closed -$897K

Similar funds

T. Rowe Price Associates's Q1 2025 Portfolio in Review

As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
  • T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
  • T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
  • T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
  • T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
  • T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.